Schizophrenia. The Schizophrenic Disorders Are Characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted.
Conditions
Interventions
Intervention 1: Control group recieve an oral atypical antipsychotic in therapeutic dose plus plasebo for eight weeks. Intervention 2: Intervention group recieve an oral Atypical antipsychotic in th
Treatment - Drugs
Control group recieve an oral atypical antipsychotic in therapeutic dose plus plasebo for eight weeks.
Intervention group recieve an oral Atypical antipsychotic in therapeutic dose plus omega3 1000mg/day per oral for eight weeks
Sponsors
Arak University Of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:age range 15-55years ,diagnosis of schizophrenia according to DSM4-TR criteria and clinical interview by psychiatrist ,informed written consent letter ,a score of at least 60 in PANSS( Positive and Negative Syndrome Scale). Exclusion criteria :Pregnancy ,lactation, substance abuse ,sever physical disease,contraindication of Omega-3
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PANSS. Timepoint: Before Intervention,4th Week,8th Week. Method of measurement: Physical Exam And Clinical Intrview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Extra Pyramidal Side Effects. Timepoint: Before Intervention And Once Every 4 Weeks. Method of measurement: Physical Examination And Clinical Interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr HmidReza Jamilian
Arak Univesity Of Medical Sciences
Outcome results
None listed